Newsroom

print
 
 

 

11/28/2017 Bio-Rad Authorizes New $250 Million Share Repurchase Program
More
11/21/2017 Bio-Rad to Webcast Investor Day 2017
More
11/02/2017 Bio-Rad Reports Third-Quarter 2017 Financial Results
More
10/16/2017 Bio-Rad to Report Third-Quarter 2017 Financial Results Thursday, November 2, 2017
More
08/03/2017 Bio-Rad Reports Second-Quarter 2017 Financial Results
More
07/10/2017 Bio-Rad to Report Second-Quarter 2017 Financial Results Thursday, August 3, 2017
More
06/12/2017 Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method
More
05/24/2017 Bio-Rad Introduces Enhanced Options with its IH-Com Data Management Software for Managing Patient Results with the IH-1000 System
More
05/04/2017 Bio-Rad Reports First-Quarter 2017 Financial Results
More
04/10/2017 Bio-Rad to Report First-Quarter 2017 Financial Results Thursday, May 4, 2017
More
03/13/2017 Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day
More
03/13/2017 Bio-Rad Intends to Propose Three New Independent Directors
More
02/23/2017 Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
More
01/18/2017 Bio-Rad to Report Fourth-Quarter and Full-Year 2016 Financial Results Thursday, February 23, 2017
More
01/16/2017 Bio-Rad To Acquire RainDance Technologies and Droplet Intellectual Property
More
01/09/2017 Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases
More
Get Help
Media Contacts

Tina Cuccia
Corporate Communications Manager
Phone: +1-510-741-6063
Email: Tina_Cuccia@bio-rad.com

Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.